Ramani Varanasi
And finally this week, clinical investment group Avillion has expanded its team by appointing Ramani Varanasi as Chief Business Officer.
Varanasi has over 18 years of biotechnology and pharmaceutical industry experience, with senior roles at companies including Merck, Millennium/Takeda and Momenta.
Lewis Cameron, CEO of Avillion, said: “We are excited to have Ramani on the Avillion team, where our key focus is the execution of co-development and financing deals with pharma and biotech companies.”